Objectives
The goal of V4L is to improve uptake rates of adult vaccination globally. Most countries do not reach the WHO and the European Union’s target of 75% influenza vaccination coverage for vulnerable groupsii .
V4L is framed by three independent yet connected intentions:
- To be a reliable source of information, evidence and good practice across sectors and disciplines on the link between adult vaccination and healthy ageing.
- To mobilize knowledge, experts and expertise through the creation and use of innovative platforms and channels of communication.
- To influence and help shape policy related to adult vaccination and at-risk groups through capacity building at the national and international level.
iWHO (2008) Vaccination greatly reduces disease, disability, death and inequity worldwide. Available at: https://www.who.int/bulletin/volumes/86/2/07-040089/en/. Last accessed: April 2020.
iiECDC (2018) Seasonal influenza vaccination and antiviral use in EU/EEA Member States. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/seasonal-influenza-antiviral-use-2018.pdf. Last accessed: April 2020.

Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.
The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.